Christian Klein Selected Research

Inflammation (Inflammations)

1/2017	Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.
9/2007	Contribution of interleukin-6/gp 130 signaling in hepatocytes to the inflammatory response in mice infected with Streptococcus pyogenes.
8/2003	ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian Klein Research Topics

Disease

100	Neoplasms (Cancer) 04/2024 - 01/2004
14	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 04/2013
11	Lymphoma (Lymphomas) 03/2024 - 02/2011
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2011
8	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2004
6	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 07/2012
6	Leukemia 12/2021 - 01/2018
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2021 - 01/2015
5	Melanoma (Melanoma, Malignant) 01/2024 - 01/2015
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 10/2004
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2021 - 01/2015
5	Arthritis (Polyarthritis) 12/2020 - 05/2015
5	Liver Diseases (Liver Disease) 01/2018 - 07/2003
4	Rheumatoid Arthritis 04/2024 - 05/2015
4	Experimental Arthritis 12/2020 - 03/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024 - 01/2017
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 01/2021
3	Cytokine Release Syndrome 11/2023 - 01/2022
3	Infections 10/2023 - 03/2003
3	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 12/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 10/2019
3	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2013
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2016
3	Disease Progression 06/2021 - 03/2014
3	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020 - 01/2011
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2015
3	Inflammation (Inflammations) 01/2017 - 08/2003
2	Multiple Sclerosis 04/2024 - 12/2017
2	Neuroinflammatory Diseases 01/2023 - 07/2013
2	Persistent Infection 01/2023 - 10/2022
2	Arteriovenous Malformations (Arteriovenous Malformation) 01/2023 - 01/2019
2	Adenocarcinoma 01/2023 - 01/2023
2	Virus Diseases (Viral Diseases) 10/2022 - 01/2018
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2022 - 12/2017
2	Bites and Stings (Sting) 01/2022 - 07/2015
2	Hypotension (Low Blood Pressure) 01/2022 - 01/2017
2	Hypoxia (Hypoxemia) 01/2022 - 12/2013
2	Wilms Tumor (Wilm's Tumor) 12/2021 - 01/2021
2	Wounds and Injuries (Trauma) 08/2021 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2020
2	Carcinogenesis 01/2020 - 09/2007
2	Neuroblastoma 12/2018 - 07/2013

Drug/Important Bio-Agent (IBA)

28	obinutuzumabIBA 02/2024 - 07/2012
27	Rituximab (Mabthera)FDA Link 04/2024 - 01/2011
26	AntibodiesIBA 02/2024 - 01/2011
26	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2005
21	Bispecific AntibodiesIBA 03/2024 - 10/2012
20	Monoclonal AntibodiesIBA 04/2024 - 01/2011
16	CytokinesIBA 11/2023 - 01/2011
15	Peptides (Polypeptides)IBA 01/2023 - 10/2004
14	AntigensIBA 01/2023 - 07/2015
9	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022 - 07/2015
8	Immunoglobulin G (IgG)IBA 01/2023 - 10/2012
7	cibisatamabIBA 01/2022 - 01/2016
7	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 07/2015
6	Carcinoembryonic AntigenIBA 02/2024 - 01/2016
6	Interleukin-2 (IL2)IBA 01/2022 - 01/2015
5	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2015
5	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2016
5	LigandsIBA 03/2022 - 02/2005
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 07/2003
5	Angiopoietin-2IBA 01/2020 - 01/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2011
4	venetoclaxIBA 01/2024 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 03/2003
4	Amyloid (Amyloid Fibrils)IBA 01/2023 - 07/2013
4	Immunoglobulins (Immunoglobulin)IBA 11/2022 - 05/2011
3	glofitamabIBA 04/2024 - 01/2024
3	ofatumumab FDA Link 04/2024 - 10/2013
3	Monophenol Monooxygenase (Tyrosinase)IBA 01/2024 - 01/2015
3	ErbB Receptors (EGF Receptor)IBA 10/2022 - 11/2012
3	Phosphotransferases (Kinase)IBA 01/2022 - 11/2015
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 12/2013
3	Neprilysin (Neutral Endopeptidase)IBA 12/2018 - 07/2013
2	ocrelizumabIBA 04/2024 - 01/2019
2	atezolizumabIBA 02/2024 - 11/2020
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2024 - 01/2017
2	ibrutinibIBA 10/2023 - 01/2023
2	Caspase 3 (Caspase-3)IBA 01/2023 - 01/2022
2	Programmed Cell Death 1 ReceptorIBA 11/2022 - 01/2018
2	epidermal growth factor receptor VIIIIBA 10/2022 - 10/2019
2	Myelin Basic ProteinIBA 03/2022 - 12/2017
2	Indicators and Reagents (Reagents)IBA 01/2022 - 07/2015
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2022 - 01/2018
2	GalliumIBA 10/2021 - 01/2019
2	Histocompatibility Antigens Class IIBA 01/2021 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 11/2013
2	Granzymes (Granzyme)IBA 01/2021 - 12/2019
2	Amyloid beta-PeptidesIBA 01/2020 - 10/2004
2	Epithelial Cell Adhesion MoleculeIBA 10/2019 - 01/2015

Therapy/Procedure

45	Therapeutics 03/2024 - 02/2004
27	Immunotherapy 10/2023 - 08/2013
9	Drug Therapy (Chemotherapy) 01/2023 - 04/2013
4	Photochemotherapy (Photodynamic Therapy) 01/2023 - 12/2020
4	Liver Transplantation 05/2019 - 05/2011
3	Aftercare (After-Treatment) 12/2017 - 09/2016
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 01/2021
2	Radiotherapy 01/2023 - 01/2023
2	Ligation 04/2020 - 07/2009